262
Najam Sharif, PhD, DSc Santen Inc, USA
Najam Sharif, PhD, DSC, was elected to the Scientific Advisory Board of The Glaucoma Foundation in May 2021 and is the recipient of the Ernst H. Barany Prize from the International Society for Eye Research (ISER) for “outstanding contributions to ocular pharmacology” in June 2021. Dr. Sharif has over 34 years of pharmaceutical research and development experience in neuroscience and ophthalmology. Dr. Sharif is a Gold Fellow of AOPT, ARVO, and British Pharmacological Society, and has received the Dr. Roger Vogel Award and the Sir James Black Award for contributions to research and drug discovery. Dr. Sharif has published over 215 papers and has had 24 patents issued. Dr. Sharif has been an ASPET member since 2010 and is a member of the Divisions for Drug Discovery and Development, Molecular Pharmacology, Neuropharmacology, and Translational and Clinical Pharmacology.
Paul V. Kaplita, PhD
Massachusetts College of Pharmacy and Health Sciences Paul V. Kaplita, PhD, was promoted to Professor of Pharmaceutical Sciences at the Massachusetts College of Pharmacy and Health Sciences, Worcester/ Manchester on July 1, 2021. He was also appointed Assistant Dean of Graduate Studies on November 1, 2021. As a postdoc, Dr. Kaplita performed toxicology studies on sodium azide and organonitriles. His tenure in pharmaceutical industry research and development included HTS assays, pharmacological characterization of natural products, and ADME-PK profiles of hit-to-lead compounds. As Professor
The Pharmacologist • December 2021
of Pharmaceutical Sciences at MCPHS, Dr. Kaplita teaches pharmacology, pathophysiology, and translational medicine, and offers opportunities for research. Dr. Kaplita has been an ASPET member since 1991 and is a member of the Divisions for Drug Discovery and Development, Pharmacology Education, and Toxicology.
Saganuwan Alhaji Saganuwan, PhD
Federal University of Agriculture Makurdi, Nigeria Saganuwan Alhaji Saganuwan, PhD, was promoted to the rank of Professor of Pharmacology and Toxicology at the Federal University of Agriculture Makurdi, Nigeria. Dr. Alhaji Saganuwan obtained his DVM, MSc (Pharmacology), PhD (Pharmacology), PGD (Science Education), and PGD (Statistics) in 1998, 2004, 2012, 2015, and 2011, respectively. He started his lecturing career in 2005, rose through ranks, and was promoted to Professor of Pharmacology and Toxicology in 2019. He has supervised over ten master and doctoral theses in the fields of pharmacology and physiology, with over 100 published articles in journals of high repute 721 article citations, and has an h index of 14. His areas of research interest are pharmacokinetics, oncology, medicinal chemistry, toxicology, clinical pharmacology, and mathematical pathology. He was head of department for 2 1/2 years and was the college registration officer for 6 years. He has presented conference papers in the U.K., United States, Australia, Japan, China, India, and Cyprus, among others. Dr. Alhaji Saganuwan has been a member of ASPET since 2015 and is a member of the Divisions for Translational and Clinical Pharmacology, Behavioral Pharmacology, Cancer Pharmacology, Drug Discovery and Development, Drug Metabolism and Disposition, Neuropharmacology, and Toxicology.